Testing living-donor uterine transplant for MRKH
Part of Women’s health & pregnancy clinical trials.
This study tests whether transplanting a uterus from a living related donor can be done safely and can help patients with MRKH type I achieve pregnancy. It also checks risks and safety issues for both the donor and recipient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient with MRKH type I (missing uterus and upper vagina) without kidney, heart, or bone problems
- You are between 18 and 38 years old
- You are in a stable relationship and want pregnancy, and you pass a psychological/mental health evaluation
- You have no past cancer history and have not needed blood transfusions
- The donor must be a related woman who has no major health problems and no serious infection or mental health condition
- Neither you nor the donor can have certain major surgery issues, clotting risks, or blood/immune compatibility problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA (your genes) to better understand Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. It may help researchers learn more about the condition, and it can include both people with MRKH and healthy family relatives.
This trial studies uterus transplant surgery to help people with “absolute uterine factor infertility” (no working uterus) become pregnant using embryos made by IVF. It checks whether the donated uterus can support pregnancy and safe delivery for participants who meet strict medical and health requirements.
This trial tests whether receiving a uterus transplant can allow someone with uterine absence to carry a pregnancy. It also looks at whether the procedure is safe for the patient and supports a future baby using frozen embryos.
This trial looks at the clinical and imaging details of MRKH syndrome, a condition present from birth affecting the uterus and vagina. It aims to improve understanding and care for those with this condition.
This study looks at why the body’s immune system may reject a transplanted uterus or a related surgery. Your results may help doctors understand rejection and improve care for future uterine transplants.
This trial studies transplanting a uterus to allow people with uterine infertility to try pregnancy. It may help some patients who cannot carry a baby because their uterus is missing or nonfunctional, but it requires careful matching and strict health screening for both recipients and donors.
Hear when a new Mayer Rokitansky Kuster Hauser Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.